Johnson & Johnson (JNJ) Total Liabilities (2009 - 2026)

Johnson & Johnson has disclosed Total Liabilities across 18 years of filings, most recently posting $119.7 billion for Q1 2026.

• Total Liabilities for Q1 2026 came in at $119.7 billion, up 3.59% year-over-year; the trailing twelve-month figure through Mar 2026 was $119.7 billion (up 3.59% YoY), and the FY2025 annual result was $117.7 billion, up 8.33% from the prior year.
• Total Liabilities came in at $119.7 billion for Q1 2026 at Johnson & Johnson, up from $117.7 billion in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $125.1 billion in Q2 2023 to a low of $94.8 billion in Q4 2023.
• The 5-year median for Total Liabilities is $109.1 billion (2024), against an average of $109.3 billion.
• Across the five-year window, Total Liabilities increased 20.7% in 2023 and decreased 18.51% in 2024, its largest moves.
• Johnson & Johnson's Total Liabilities stood at $100.5 billion in 2022, then dropped by 1.73% to $98.8 billion in 2023, then grew by 9.95% to $108.6 billion in 2024, then grew by 8.33% to $117.7 billion in 2025, then rose by 1.74% to $119.7 billion in 2026.
• The last three Total Liabilities figures came in at $119.7 billion (Q1 2026), $117.7 billion (Q4 2025), and $113.5 billion (Q3 2025), per Business Quant data.